Skip to Main Content

Paper Details

Radiation Treatment, ATM, BRCA1/2, and CHEK2*1100delC Pathogenic Variants and Risk of Contralateral Breast Cancer.
J Natl Cancer Inst
17
2020
1100delC, ATM, ATM missense variants, BRCA1/2, BRCA1/2 pathogenic variant, Breast Cancer, CBC, CHEK2*1100delC, CHEK2*1100delC Pathogenic Variants, breast cancer, contralateral breast cancer, genes, pathogenic germline variants, pathogenic variants, unilateral breast cancer, women
Author NameAffiliation
Esther M JohnStanford University
Charles F LynchUniversity of Iowa
John D BoiceVanderbilt University Medical Center, Vanderbilt-Ingram Cancer Center
Julia A KnightUniversity of Toronto, Dalla Lana School of Public Health Science
Julia A KnightLunenfeld-Tanenbaum Research Institute
Sharon N TeraokaGenetics Institute and Department of Pathology, University of Florida
Ronglai ShenMemorial Sloan Kettering Cancer Center
Roy E ShoreNYU School of Medicine
Daniel O StramUniversity of Southern California
Duncan C ThomasUniversity of Southern California
Kathleen E MaloneFred Hutchinson Cancer Research Center
Leslie BernsteinBeckman Research Institute, City of Hope National Medical Center
Nadeem RiazMemorial Sloan Kettering Cancer Center
Simon N PowellMemorial Sloan Kettering Cancer Center
David E GoldgarUniversity of Utah
David E GoldgarUniversity of Utah
Patrick ConcannonGenetics Institute and Department of Pathology, University of Florida
Jonine L BernsteinMemorial Sloan Kettering Cancer Center
  • 1 - 18

Datasets

Release 1.2